N-α,N-δ-Dicarbobenzoxy-D-ornithine
Need Assistance?
  • US & Canada:
    +
  • UK: +

N-α,N-δ-Dicarbobenzoxy-D-ornithine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
CBZ-Amino Acids
Catalog number
BAT-006898
CAS number
13594-49-5
Molecular Formula
C21H24N2O6
Molecular Weight
400.42
N-α,N-δ-Dicarbobenzoxy-D-ornithine
IUPAC Name
(2R)-2,5-bis(phenylmethoxycarbonylamino)pentanoic acid
Synonyms
Z-D-Orn(Z)-OH
Purity
99%
Density
1.258±0.06 g/cm3(Predicted)
Boiling Point
653.3±55.0 °C(Predicted)
Storage
Store at 2-8 °C
InChI
InChI=1S/C21H24N2O6/c24-19(25)18(23-21(27)29-15-17-10-5-2-6-11-17)12-7-13-22-20(26)28-14-16-8-3-1-4-9-16/h1-6,8-11,18H,7,12-15H2,(H,22,26)(H,23,27)(H,24,25)/t18-/m1/s1
InChI Key
VBENHRFIEOLOJJ-GOSISDBHSA-N
Canonical SMILES
C1=CC=C(C=C1)COC(=O)NCCCC(C(=O)O)NC(=O)OCC2=CC=CC=C2
1. Stimuli-responsive polypeptide nanogels for trypsin inhibition
Petr Šálek, Jana Dvořáková, Sviatoslav Hladysh, Diana Oleshchuk, Ewa Pavlova, Jan Kučka, Vladimír Proks Beilstein J Nanotechnol. 2022 Jun 22;13:538-548. doi: 10.3762/bjnano.13.45. eCollection 2022.
A new type of hydrophilic, biocompatible, and biodegradable polypeptide nanogel depots loaded with the natural serine protease inhibitor α1-antitrypsin (AAT) was applied for the inhibition of the inflammatory mediator trypsin. Two types of nanogels were prepared from linear synthetic polypeptides based on biocompatible and biodegradable poly[N 5-(2-hydroxyethyl)-ʟ-glutamine-ran-N 5-propargyl-ʟ-glutamine-ran-N 5-(6-aminohexyl)-ʟ-glutamine]-ran-N 5-[2-(4-hydroxyphenyl)ethyl)-ʟ-glutamine] (PHEG-Tyr) or biocompatible N α-ʟ-lysine-grafted α,β-poly[(2-propyne)-ᴅ,ʟ-aspartamide-ran-(2-hydroxyethyl)-ᴅʟ-aspartamide-ran-(2-(4-hydroxyphenyl)ethyl)-ᴅʟ-aspartamide] (N α-Lys-NG). Both nanogels were prepared by HRP/H2O2-mediated crosslinking in inverse miniemulsions with pH and temperature-stimuli responsive behavior confirmed by dynamic light scattering and zeta potential measurements. The loading capacity of PHEG-Tyr and N α-Lys-NG nanogels and their release profiles were first optimized with bovine serum albumin. The nanogels were then used for loading and release of AAT. PHEG-Tyr and N α-Lys-NG nanogels showed different loading capacities for AAT with the maximum (20%) achieved with N α-Lys-NG nanogel. In both cases, the nanogel depots demonstrated a burst release of AAT during the first 6 h, which could be favorable for quick inhibition of trypsin. A consequent pilot in vitro inhibition study revealed that both PHEG-Tyr and N α-Lys-NG nanogels loaded with AAT successfully inhibited the enzymatic activity of trypsin. Furthermore, the inhibitory efficiency of the AAT-loaded nanogels was higher than that of only AAT. Interestingly, also non-loaded PHEG-Tyr and N α-Lys-NG nanogels were shown to effectively inhibit trypsin because they contain suitable amino acids in their structures that effectively block the active site of trypsin.
Online Inquiry
Verification code
Inquiry Basket